This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hearse, D. J. Articles by Braimbridge, M. V. Search for Related Content PubMed PubMed Citation Articles by Hearse, D. J. Articles by Braimbridge, M. V. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB GLUCOSE

Circulation, Vol 54, 193-202, Copyright © 1976 by American Heart Association

ARTICLES

Cellular protection during myocardial ischemia: the development and characterization of a procedure for the induction of reversible ischemic arrest

DJ Hearse, DA Stewart and MV Braimbridge

An isolated perfused working rat heart model was used to investigate the extent to which various protective agents, used either singly or in combination, were able to increase the resistance of the heart to periods of transient ischemia. The aim of the studies was to develop a solution which, if infused into the coronary vessels just prior to the onset of ischemia, would rapidly induce arrest and would also counteract several of the deleterious cellular changes known to occur during myocardial ischemia. Agents with induce cardiac arrest, modify cellular ion loss, affect substrate utilization, energy production and energy stores, affect coronary vessel diameter and cell swelling, prevent dysrhythmias, and affect metabolic rate were investigated. The additive effects of these agents were evaluated. An aqueous solution was formulated which contained high concentrations of potassium and magnesium, in combination with adenosine triphosphate, creatine phosphate and procaine. This solution increased the recovery of the ischemic (37 degrees C for 30 min) rat heart from 0% to 93%. The safe period of ischemia could be further increased by the use of hypothermia.

This article has been cited by other articles:

				V. Venugopal, A. Ludman, D. M. Yellon, and D. J. Hausenloy 'Conditioning' the heart during surgery Eur. J. Cardiothorac. Surg., June 1, 2009; 35(6): 977 - 987. [Abstract] [Full Text] [PDF]

				R. M. Mentzer Jr, M. S. Jahania, and R. D. Lasley Myocardial Protection Card. Surg. Adult, January 1, 2008; 3(2008): 443 - 464. [Full Text]

				C. Schlensak Myocardial protection in congenital heart surgery MMCTS, November 29, 2005; 2005(1129): 729. [Abstract] [Full Text] [PDF]

				Q. Yang and G.-W. He Effect of Cardioplegic and Organ Preservation Solutions and Their Components on Coronary Endothelium-Derived Relaxing Factors Ann. Thorac. Surg., August 1, 2005; 80(2): 757 - 767. [Abstract] [Full Text] [PDF]

				M. A. Chaudhry, P. R. Belcher, S. P. Day, E. W. Muriithi, and D. J. Wheatley Erythrocyte-containing versus crystalloid cardioplegia in the rat: effects on myocardial capillaries Ann. Thorac. Surg., March 1, 2003; 75(3): 890 - 898. [Abstract] [Full Text] [PDF]

				J. Vinten-Johansen, Z.-Q. Zhao, J. S. Corvera, C. D. Morris, J. M. Budde, V. H. Thourani, and R. A. Guyton Adenosine in myocardial protection in on-pump and off-pump cardiac surgery Ann. Thorac. Surg., February 1, 2003; 75(2): S691 - 699. [Abstract] [Full Text] [PDF]

				C. S. Cox Jr, S. J. Allen, H. Sauer, and G. A. Laine Improved Myocardial Function Using a Na+/H+ Exchanger Inhibitor During Cardioplegic Arrest and Cardiopulmonary Bypass Chest, January 1, 2003; 123(1): 187 - 194. [Abstract] [Full Text] [PDF]

				R. M. Mentzer Jr., M. S. Jahania, and R. D. Lasley Myocardial Protection Card. Surg. Adult, January 1, 2003; 2(2003): 413 - 438. [Full Text]

				C. George Perfusion: a view from the British Heart Foundation Perfusion, July 1, 2002; 17(4): 241 - 242. [Abstract] [PDF]

				C. S. Cox Jr, H. Sauer, S. J. Allen, L. M. Buja, and G. A. Laine Sodium/hydrogen-exchanger inhibition during cardioplegic arrest and cardiopulmonary bypass: An experimental study J. Thorac. Cardiovasc. Surg., May 1, 2002; 123(5): 959 - 966. [Abstract] [Full Text] [PDF]

				K. Nakamura, I. Schmidt, C. C. Gray, A. Dewar, S. Rothery, N. J. Severs, M. H. Yacoub, and M. Amrani The effect of chronic L-arginine administration on vascular recovery following cold cardioplegic arrest in rats Eur. J. Cardiothorac. Surg., April 1, 2002; 21(4): 753 - 759. [Abstract] [Full Text] [PDF]

				M. Murtra The adventure of cardiac surgery Eur. J. Cardiothorac. Surg., February 1, 2002; 21(2): 167 - 180. [Full Text] [PDF]

				R Tosson, D Buchwald, K Klak, and A Laczkovics The impact of normothermia on the outcome of aortic valve surgery Perfusion, July 1, 2001; 16(4): 319 - 324. [Abstract] [PDF]

				J. Vinten-Johansen, V. H. Thourani, R. S. Ronson, J. E. Jordan, Z.-Q. Zhao, M. Nakamura, D. Velez, and R. A. Guyton Broad-spectrum cardioprotection with adenosine Ann. Thorac. Surg., November 1, 1999; 68(5): 1942 - 1948. [Abstract] [Full Text] [PDF]

				Y. Paz, J. Gurevitch, I. Frolkis, M. Matsa, A. Kramer, C. Locker, R. Mohr, and G. Keren Effects of an Angiotensin II Antagonist on Ischemic and Nonischemic Isolated Rat Hearts Ann. Thorac. Surg., February 1, 1998; 65(2): 474 - 479. [Abstract] [Full Text] [PDF]

				M. Hachida, M. Nonoyama, Y. Bonkohara, N. Hanayama, S. Saitou, T. Maeda, A. Ohkado, H. Lu, and H. Koyanagi Clinical Assessment of Prolonged Myocardial Preservation for Patients With a Severely Dilated Heart Ann. Thorac. Surg., July 1, 1997; 64(1): 59 - 63. [Abstract] [Full Text]

				J. Gurevitch, D. Pevni, I. Frolkis, M. Matsa, Y. Paz, R. Mohr, and V. Yakirevich Captopril in Cardioplegia and Reperfusion: Protective Effects on the Ischemic Heart Ann. Thorac. Surg., March 1, 1997; 63(3): 627 - 633. [Abstract] [Full Text]

				D. J. Chambers, K. Haire, N. Morley, L. Fairbanks, E. Strumia, C. P. Young, and G. E. Venn St. Thomas' Hospital Cardioplegia: Enhanced Protection With Exogenous Creatine Phosphate Ann. Thorac. Surg., January 1, 1996; 61(1): 67 - 75. [Abstract] [Full Text]

				M. Amrani, A. H. Chester, J. Jayakumar, and M. H. Yacoub AGING REDUCES POSTISCHEMIC RECOVERY OF CORONARY ENDOTHELIAL FUNCTION J. Thorac. Cardiovasc. Surg., January 1, 1996; 111(1): 238 - 245. [Abstract] [Full Text]

				A. R. Cordell Milestones in the Development of Cardioplegia Ann. Thorac. Surg., September 1, 1995; 60(3): 793 - 796. [Abstract] [Full Text]

				S. Sugimoto, P. E. Puddu, F. Monti, M. Schiariti, P. P. Campa, and B. Marino Pretreatment with the adenosine triphosphate-sensitive potassium channel opener nicorandil and improved myocardial protection during high-potassium cardioplegic hypoxia J. Thorac. Cardiovasc. Surg., September 1, 1994; 108(3): 455 - 466. [Abstract] [Full Text]

				J. Gurevitch, J. Barak, E. Hochhauser, Y. Paz, and V. Yakirevich Aprotinin improves myocardial recovery after ischemia and reperfusion:Effects of the drug on isolated rat hearts J. Thorac. Cardiovasc. Surg., July 1, 1994; 108(1): 109 - 118. [Abstract] [Full Text]

				M. Shechter, E. Kaplinsky, and B. Rabinowitz The Rationale of Magnesium Supplementation in Acute Myocardial Infarction: A Review of the Literature Arch Intern Med, November 1, 1992; 152(11): 2189 - 2196. [Abstract] [PDF]

				C. Munsch Review article : Blood cardioplegia Perfusion, October 1, 1991; 6(4): 245 - 252. [PDF]